Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec:2:1-4.
doi: 10.1200/CCI.18.00070.

Intersection of Digital Health and Oncology

Affiliations
Review

Intersection of Digital Health and Oncology

Adam P Dicker et al. JCO Clin Cancer Inform. 2018 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc.

Adam P. Dicker

Leadership: Department of Defense Prostate Cancer Research Program, NRG Oncology, American Society for Radiation Oncology

Consulting or Advisory Role: EMD Serono, Ferring Pharmaceuticals, Janssen, RedHill Biopharma, Self Care Catalyst, Celldex, Johnson & Johnson, CVS

Research Funding: Prostate Cancer Foundation

Travel, Accommodations, Expenses: Merck KGaA, Ferring Pharmaceuticals, Self Care Catalyst

Heather S.L. Jim

Consulting or Advisory Role: Janssen, RedHill BioPharma

References

    1. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197–198. - PMC - PubMed
    1. Denis F, Lethrosne C, Pourel N, et al. Randomized trial comparing a Web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017 doi: 10.1093/jnci/djx029. - DOI - PubMed
    1. Peterson SK, Garden AS, Shinn EH, et al. Using mobile and sensor technology to identify early dehydration risk in head and neck cancer patients undergoing radiation treatment: Impact on symptoms. J Clin Oncol. 2018;36 suppl; abstr 6063.
    1. Cox SA, Lane A, Volchenboum SL. Use of wearable, mobile, and sensor technology in cancer clinical trials. JCO Clin Cancer Inform. . doi: 10.1200/CCI.17.00147. - DOI - PubMed
    1. Gonzalez BD. Promise of mobile health (mHealth) technology to reduce disparities in patients with cancer and survivors. JCO Clin Cancer Inform. . doi: 10.1200/CCI.17.00141. - DOI - PMC - PubMed

Publication types